회사 개요
DENTSPLY SIRONA Inc. is a global enterprise dedicated to the development, manufacturing, and marketing of dental equipment supported by cloud-enabled solutions, alongside dental products and healthcare consumable products utilized in urology and enterology. The company operates within the Healthcare sector, specifically the Medical Instruments & Supplies industry, a domain characterized by high barriers to entry, stringent regulatory requirements, and a reliance on continuous technological innovation to address patient care needs. This entity maintains a substantial operational scale, employing approximately 14,000 individuals globally and holding a market capitalization of $2.39B. Its trailing twelve-month revenue stands at $3.68B, which, combined with its employee base, indicates a significant market presence that allows the firm to influence pricing dynamics and supply chain efficiency within the specialized medical device market.
재무 건전성
The company reported a total revenue of $3.68B for the trailing twelve months, yet recorded a net income loss of $-598,000,000, while generating an EBITDA of $597.00M. The substantial disparity between the positive EBITDA and the negative net income reveals a cost structure burdened by significant interest expenses or non-operating costs that consume operating profits before reaching the bottom line. Despite the net loss, the company generated free cash flow of $106.38M, indicating a degree of financial flexibility that allows for capital expenditures or debt servicing without immediate dilution or equity issuance. The gross margin is reported at 50.0%, suggesting efficient production costs relative to sales, whereas the operating margin of 1.8% indicates that overhead and administrative expenses are eroding operating profits significantly. The profit margin stands at -16.2%, confirming that the company is currently unprofitable on a net basis due to the aforementioned non-operating factors. On the balance sheet, the company holds $354.00M in cash against total debt of $2.48B, resulting in a debt-to-equity ratio of 185.00, which characterizes a highly leveraged financial position where debt obligations substantially exceed equity capitalization. The current ratio of 1.51 suggests that the company possesses sufficient current assets to cover its short-term liabilities, maintaining a baseline of short-term liquidity despite the high leverage. Furthermore, the return on equity is -36.4% and the return on assets is 2.7%, metrics that collectively reveal management's current ineffectiveness in generating net returns on the shareholders' investment and the overall asset base, respectively.
밸류에이션 평가
Valuation metrics for DENTSPLY SIRONA Inc. present a complex picture, with a trailing P/E ratio listed as N/A due to negative net income, while the forward P/E is calculated at 7.71. The absence of a trailing P/E implies that the market cannot value the stock based on historical earnings but must instead rely on forward-looking estimates which suggest an expectation of future profitability or earnings recovery. The price-to-book ratio is 1.79, indicating that the market values the company at a 79% premium over its book value, which may reflect intangible assets or future growth potential despite current losses. Alternative valuation measures include a price-to-sales ratio of 0.65 and an EV/EBITDA of 7.57, suggesting that the stock is priced at a significant discount relative to its sales and earnings before interest, taxes, depreciation, and amortization, often seen in cyclical or turnaround sectors. Regarding price movement, the 52-week high is $17.18 and the low is $9.85, providing a range within which the stock has traded over the past year. The beta value is 1.00, which indicates that the stock's price volatility moves in tandem with the broader market, lacking significant idiosyncratic risk or defensive characteristics relative to the general equity index.
Growth & Income
The company demonstrated a revenue growth rate of 6.2% year-over-year, whereas earnings growth is listed as N/A due to the current negative net income position. This divergence implies that while top-line sales are expanding, the bottom-line profitability has not yet caught up, likely due to the high fixed costs or interest burdens previously mentioned. As a dividend payer, the company offers a dividend yield of 5.0% with a payout ratio of 28.8%. The relatively low payout ratio of 28.8% against a negative net income suggests that the dividend is funded primarily by cash flow rather than retained earnings, which presents a sustainability risk if earnings do not improve soon. Consequently, the company is not reinvesting earnings into growth in the traditional sense of plowing back profits, but rather maintaining a high yield while managing a leveraged balance sheet. In summary, the overall profile combines moderate revenue expansion with a high-yield dividend distribution, set against a backdrop of current net losses and elevated debt levels that investors must weigh when assessing the firm's trajectory.